TUSTIN, Calif., January 24, 2025--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid:
Sabra Health Care REIT, Inc.
Common Stock (CUSIP # 78573L106)
Record |
Payable |
Distribution |
Total |
Non-Qualified |
Qualified |
Non-Dividend |
||||||||||||||||
02/13/2024 |
02/29/2024 |
$ |
0.3000000 |
$ |
0.2649911 |
$ |
0.2649911 |
$ |
0.0000000 |
$ |
0.0350089 |
|||||||||||
05/20/2024 |
05/31/2024 |
0.3000000 |
0.2649911 |
0.2649911 |
0.0000000 |
0.0350089 |
||||||||||||||||
08/19/2024 |
08/30/2024 |
0.3000000 |
0.2649911 |
0.2649911 |
0.0000000 |
0.0350089 |
||||||||||||||||
11/15/2024 |
11/29/2024 |
0.3000000 |
0.2649911 |
0.2649911 |
0.0000000 |
0.0350089 |
||||||||||||||||
$ |
1.2000000 |
$ |
1.0599644 |
$ |
1.0599644 |
$ |
0.0000000 |
$ |
0.1400356 |
|||||||||||||
100.00% |
88.33% |
11.67% |
||||||||||||||||||||
The 2024 Non-Qualified Ordinary Dividends are also reported on Form 1099-DIV, Box 5, Section 199A Dividends. Treasury Regulation §1.199A-3(c)(2)(ii) requires that shareholders hold their REIT shares for at least 45 days in order for the dividends to be treated as Section 199A Dividends. Shareholders should consult with their tax advisors to determine whether this requirement affects any portion of the dividends included in Box 5.
Pursuant to Treas. Reg. § 1.1061-6(c), the Company reports that for purposes of section 1061 of the Internal Revenue Code, the One Year Amounts Disclosure and the Three Year Amounts Disclosure are $0.00 with respect to direct and indirect holders of "applicable partnership interests".
About Sabra
Sabra Health Care REIT, Inc. (Nasdaq:SBRA), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250124305467/en/
Contacts
Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。